tirzepatide and gallbladder problems Why is disease a concern with (Mounjaro)? Is it safe for a

Cureus 12 , e11735 (2020)

2 Top-line results from the SELECT cardiovascular outcomes trial showed reduction in risk of stroke, myocardial infarction, or cardiovascular death with semaglutide in patients with established cardiovascular disease

Coulter DL, Allen RJ: Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy

Poorly managed or uncontrolled DM can lead to major complications such as neuropathy, nephropathy, and retinopathy with consequent serious morbidity (Narayan et al

A substudy of the phase 2 clinical trial specifically examined body composition changes using dual-energy X-ray absorptiometry (DEXA), the gold standard for measuring lean and fat mass